Effects of an internet interactive empowerment-based self-management protocol on physiological indicators in adults with metabolic syndrome

Effects of an internet interactive empowerment-based self-management protocol on physiological indicators in adults with metabolic syndrome: Pilot study

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

ISRCTN

Registry ID

ISRCTN95637143

Enrollment

Registered

2021-07-05

Start date

2018-03-02

Completion date

Unknown

Last updated

2022-02-21

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Intervention effects on reduction of body weight, body mass index, and waist circumference in adults with metabolic syndrome. Nutritional, Metabolic, Endocrine

Interventions

This pilot randomized controlled trial had a two-group, pretest-posttest (at 6th week and 3rd month), double-blind (participants and outcome assessors) design randomized block design. Convenience samp

a system manual

health education, basic information, self-awareness, and self-management pages

participants’ personal self-management history records

and a health professional contact page. The comparison group received internet self-management health education and usual care for 6 weeks.

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: 1. Metabolic syndrome with three or more of the following conditions: 1.1. Waist circumference =90cm for males or =80cm for females 1.2. Triglycerides =150mg/dl 1.3. High-density lipoprotein cholesterol <40mg/dl for males or <50mg/dl for females 1.4. Blood pressure =130/85 mmHg 1.5. Fasting glucose =100mg/dl 2. Age =20 years 3. No visual or hearing impairment or psychological disorder 4. Conscious state and ability to communicate in Mandarin or Taiwanese 5. Literacy with at least a primary school education 6. Weekly internet browsing at home

Exclusion criteria

Exclusion criteria: 1. Using medication for hyperlipidemia, hypertension, or diabetes 2. Other serious metabolic complications, such as kidney failure with hemodialysis or heart failure

Design outcomes

Primary

Measure	Time frame
At baseline, week 6, and week 12: 1. Body weight (kg) 2. Waist circumference (cm) 3. Body mass index (kg/m²)	—

Secondary

Measure	Time frame
Measured by blood test unless noted at baseline, week 6, and week 12: 1. Fasting glucose 2. Glycated hemoglobin 3. Total cholesterol level 4. Triglyceride level 5. High-density lipoprotein cholesterol levels 6. Blood pressure (mmHG, sphygmomanometer)	—

Countries

Taiwan

Outcome results

None listed

Source: ISRCTN (via WHO ICTRP) · Data processed: Feb 4, 2026